Πέμπτη 5 Σεπτεμβρίου 2013

Antibiotic Exposure in Infancy Linked to Food Allergies


Antibiotic Exposure in Infancy Linked to Food Allergies

Kate Johnson
Feb 28, 2013

SAN ANTONIO, Texas — Exposure to more than 2 courses of antibiotics in the first year of life is associated with a significantly increased rate of food allergy, according to research presented here at the American Academy of Allergy, Asthma & Immunology 2013 Annual Meeting.
"We believe it may be related to a disruption of normal gut flora," lead investigator Bryan Love, PharmD, from the South Carolina College of Pharmacy in Columbia, toldMedscape Medical News.
"Systemic antibiotics not only kill bacteria causing an infection...[they] are also distributed to other parts of our body where they can kill susceptible bacteria that are part of our normal flora — especially in the gastrointestinal tract," Dr. Love explained.
In their retrospective case–control study, presented as a late-breaking abstract at the meeting, Dr. Love and colleagues found an almost 2-fold increase in food allergy in children exposed to 3 or more courses of antibiotics between the ages of 7 and 12 months.
 
We believe it may be related to a disruption of normal gut flora.
 
Dr. Love explained that younger children (from birth to 6 months) also faced an increased risk with exposure (odds ratio, 1.43), although he did not present those data.
In both age groups, rates of food allergy were significantly higher (P < .0001), he told Medscape Medical News.
The investigators used South Carolina Medicaid billing data to identify more than 1100 children diagnosed with food allergy before the age of 3 and 6433 control subjects. They matched cases and controls by birth year, sex, and race.
Subjects in the 2 groups received a total 8046 courses of antibiotics, including penicillin (54%), cephalosporins (21%), macrolides (18%), and sulfonamides (7%).
The investigators controlled for asthma, atopic dermatitis, and eczema. "We know these patients tend to be more prone to food allergy," Dr. Love said. "They're also more likely to receive antibiotics, so we wanted to control for that."
Logistic regression analysis showed that subjects with food allergy were more likely than control subjects to have received a course of antibiotics.
Table. Antibiotic Exposure Before 12 Months
OutcomeFood Allergy GroupControl GroupP Value
At least 1 course of antibiotic77%66%<.001
Mean number of antibiotic courses2.651.84<.001
Time to first antibiotic181.5 days190.1 days.009
One or 2 rounds of antibiotics did not significantly increase the rate of food allergy, the investigators report, but 3 or 4 did.
Table. Risk for Food Allergy With Antibiotic Exposure
Antibiotic ExposureOdds Ratio
Before 12 months1.71
Between 0 and 6 months1.43
Between 7 and 12 months1.98
3 courses1.45
4 courses1.60
5 courses2.15
"Whilewe understand that this type of study can't assign causality, it does appear that this needs to be looked at further. This could be a reason for increasing rates of food allergy," Dr. Love said.
Katie Allen, MD, from the Murdoch Children's Research Institute at the University of Melbourne in Australia, noted that it is not clear how the investigators controlled for eczema in this study.
"In our HealthNuts cohort of 5300 kids [Clin Exp Allergy.2010;40:1516-1522], we found a high rate of antibiotic use in kids with allergy. Unfortunately, almost all of it was due to the fact that they had infected eczema," she said.
"We think antibiotics being associated with food allergy is a spurious association, but it's really only associated with the treatment of infected eczema." Dr. Allen toldMedscape Medical News.
She added that "we know there's a lot of eczema in the first year of life. It may well be that antibiotic use is associated with eczema, and we know that eczema is associated with food allergy."
She thinks there is evidence that the widespread use of antibiotics has changed the microbiome at the population level. "But we need to do due diligence at the individual level to ensure that we're not making a spurious association," she noted.
"It's a wonderful hypothesis and we're all hotly looking at it, but...we need to be very careful to make sure that the work is of the highest quality and we don't jump on the bandwagon before we've looked at it properly," Dr. Allen noted.
This study was funded by the US Department of Health and Human Services Health Resources and Services Administration. The investigators and Dr. Allen have disclosed no relevant financial relationships..
American Academy of Allergy, Asthma & Immunology (AAAAI) 2013 Annual Meeting: Abstract L14. Presented February 26, 2013.

Τετάρτη 4 Σεπτεμβρίου 2013

Infants With Bronchiolitis: What Treatment Is Best?


Infants With Bronchiolitis: What Treatment Is Best?

William T. Basco, Jr., MD, MS
Aug 23, 2013

Racemic Adrenaline and Inhalation Strategies in Acute Bronchiolitis

Skjerven HO, Hunderi JO, Brügmann-Pieper SK, et al

N Engl J Med. 2013;368:2286-2293

Study Summary

Although inhaled epinephrine (adrenaline) has been found to reduce the need for hospitalization when given to patients with bronchiolitis in the emergency department, it is not clear whether continuing nebulized epinephrine in the hospital will alter the hospital course of bronchiolitis in children. This multicenter, double-blind trial, conducted in Norway, used a 2 x 2 factorial design in which both the inhaled substance (epinephrine vs saline) and the frequency of delivery (on demand vs scheduled) were randomized. This resulted in 4 study groups of children who received the 2 different interventions in different combinations.
A total of 404 children (59% boys) were enrolled in 2010 and 2011. All children were younger than 12 months (mean age, 4.2 months) and met a clinical definition of bronchiolitis; all had significant symptoms, meaning that patients with mild symptoms were generally excluded. Most (81%) of the infants had bronchiolitis due to respiratory syncytial virus. The trial excluded patients with chronic medical conditions that would otherwise potentially alter treatment, as well as any who had received steroids within 4 weeks of presenting. In Norway, hospitalized children with bronchiolitis do not receive glucocorticoids or beta-adrenergic agonists.
The primary outcome of interest was hospital length of stay. The investigators evaluated several secondary outcomes, including whether nasogastric tube feedings were used and whether patients required oxygen or ventilatory support.

Study Findings

The randomization was roughly equal, resulting in approximately 100 patients in each of the 4 factorial groups. The discontinuation rate was approximately equal among the groups, except in the group that received inhaled saline on a fixed schedule; 26% of the infants in that cohort discontinued the study, compared with 17%-20% in the remaining 3 groups. Overall, 321 infants completed the study (82% of the racemic epinephrine groups and 77% of the inhaled saline groups).
Length of stay did not differ between the infants who received inhaled racemic epinephrine and those who received saline, with Kaplan-Meier plots of the 2 groups closely or completely overlapping through almost all of the inpatient period. In contrast, there was a slight divergence between the Kaplan-Meier curves for infants who received on-demand inhalation therapy and those who received fixed inhalation, and the curves favored those who received on-demand therapy. The infants who received on-demand therapy received a mean of 12 inhalations, compared with 17 among those who received inhalations on a fixed schedule.
When secondary outcomes grouped by inhalation substance were examined, there were no differences between the infants who received racemic epinephrine vs saline, including need for oxygen supplementation, nasogastric tube feeding, or ventilatory support. However, when secondary outcomes were grouped by inhalation schedule, the infants who received inhalation on a fixed schedule more commonly received oxygen (48.7% vs 38.3% of those who received on-demand therapy) and also had a higher frequency of receiving ventilatory support (10.8% vs 4.0%).
Length of stay was an average of 13.7 hours shorter for infants who received inhalations on demand. Age was related to length of stay, with younger infants generally staying longer. However, subgroup analysis by age did not reveal a difference in the effectiveness of racemic epinephrine.
The benefit of on-demand inhalations appeared to be confined to the younger infants (< 3 months old), and length of stay was shorter if treatments were given on demand. Among infants 3 months of age or older, inhalation frequency was not related to hospital length of stay.
Skjerven and colleagues concluded that among infants with acute bronchiolitis, inhalations of adrenaline did not shorten hospital length of stay. On-demand administration of inhalations seemed to decrease the duration of hospitalization.

Viewpoint

Skjerven and colleagues are correct to point out in the discussion section that one should be careful to remember the sample of infants in which this intervention was tested. First, the interventions were tested among infants with bronchiolitis, so it is not clear whether one might expect similar outcomes in older toddlers with bronchiolitis. Furthermore, these were young infants with bronchiolitis, not infants with viral-induced symptoms that may or may not be classic bronchiolitis.
I don't point out these limitations on generalizability to suggest that I am optimistic that inhaled racemic epinephrine offers promise for other potential age groups of children with bronchiolitis. In fact, I would characterize the general landscape of bronchiolitis trials as follows: For almost any therapeutic approach tested in the past 15 years (systemic corticosteroids, inhaled hypertonic saline, inhaled beta-agonists, or inhaled racemic epinephrine), initial small, single-center studies have often appeared promising. For the most part, however, these initial, smaller studies were followed by more extensive, multicenter, double-blind studies that have not generally shown any benefit of aggressive intervention once a young infant has been admitted to the hospital for bronchiolitis. So, the state-of-the-art care for these infants is still mostly supportive.

Τετάρτη 21 Αυγούστου 2013

Νεότερα στην αντιμετώπιση της γαστρεντερίτιδας στα παιδιά

Νεα δεδομένα για το Αιμαγγείωμα στα παιδιά

An Alternative Diagnostic Algorithm for Detecting Pediatric Melanomas


An Alternative Diagnostic Algorithm for Detecting Pediatric Melanomas

Graeme M. Lipper, MD
Jul 08, 2013

Pediatric Melanoma: Results of a Large Cohort Study and Proposal for Modified ABCD Detection Criteria for Children

Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M

J Am Acad Dermatol. 2013;68:913-925

Study Summary

Pediatric melanomas are rare, with patients younger than 20 years of age accounting for 2% of reported melanomas and prepubertal children accounting for only 0.4%.[1] Unfortunately, juvenile melanoma may be misdiagnosed due to a low index of suspicion, absence of conventional ABCDE diagnostic criteria (Asymmetry, Border irregularity, Color variegation, Diameter > 6 mm, Enlarging lesion) and ambiguous histopathology.[2-4] Is there a better diagnostic algorithm for detecting pediatric melanomas?
To address this question, Cordoro and colleagues looked at a cohort of children (< 20 years old) diagnosed with melanoma (N = 60) or ambiguous melanocytic tumors treated as melanoma (N = 10) over a 25-year period of time. These 70 patients were further subdivided into 2 groups: Group A (prepubertal, 0-10 years old, n = 19) and Group B (pubertal, 11-19 years old, n = 51).
Cordoro and colleagues analyzed these pediatric melanoma cases for demographic characteristics, primary lesion characteristics, histopathological characteristics, prevalence of sentinel lymph node and distant metastases, molecular features, melanoma staging, and survival. They made the following main observations:
  1. Sixty percent of prepubertal melanomas (Group A) and 40% of melanomas presenting near or during puberty (Group B) lacked conventional ABCDE criteria.
  2. Clinical features associated with pediatric melanomas included: amelanosis, bleeding, "bumps" (nodularity), uniform color, variable diameter, and de novo development.
  3. The majority of prepubertal melanomas were amelanotic (76%).
  4. Almost 100% of pediatric melanomas presented with growing ("evolving" or "enlarging") lesions.
  5. Forty-four percent of these pediatric melanomas could not be histopathologically classified into a current melanoma subtype. Most pediatric melanomas showed nodular, spitzoid, or "unclassifiable" histopathological features.
  6. Clinically, pediatric melanomas presented at a more advanced stage and behaved more aggressively than melanomas presenting in adults.
  7. Melanoma risk factors are similar for children and adults (family history of melanoma, dysplastic or numerous melanocytic nevi, immunosuppression, xeroderma pigmentosum).

Viewpoint

This retrospective cohort study confirms that conventional ABCDE criteria will fail to detect pediatric melanomas in a majority of cases, especially in prepubertal children. In contrast, Cordoro and colleagues proposed an alternative set of ABCD criteria for children: Amelanotic bleeding, "Bump," Color uniformity, De novo appearance, any diameter.
In children under 10 years of age, most melanomas were amelanotic and presented as rapidly enlarging nodules, so lesions presenting with these features should be treated as highly suspicious. It should also be noted that most pediatric melanomas, at least in this cohort, presented with nodular, Spitzoid, or unclassifiable histopathology. In this context, dermatopathologists should be aware that melanomas in this age group may be challenging to diagnose and often do not fit conventional melanoma subtypes (superficial spreading, nodular, acral lentiginous).

Σάββατο 17 Αυγούστου 2013

Fresh, Unprocessed Baby Foods Tied to Less Allergy


Fresh, Unprocessed Baby Foods Tied to Less Allergy

Aug 09, 2013
By Kerry Grens
NEW YORK (Reuters Health) Aug 09 - Babies who ate more fruits and vegetables and fewer packaged foods were less likely to develop food allergies in a new study that looked at overall diet patterns instead of just specific foods.
"We have been aware that certain diets seem to reduce the risk of allergy in infants," said Dr. Magnus Wickman, a professor at the Karolinska Institute in Stockholm, Sweden, who was not involved in the study.
"The mechanism behind that is that we think that different kinds of fatty acids and antioxidants, different kinds of vitamins and essential minerals are good for your health and also prevent allergy," he said.
Researchers estimate that up to 8% of children have a food allergy.
Parents are sometimes advised to avoid certain foods as a means of preventing food allergies from starting. But Kate Grimshaw, lead author of the new study and a researcher at the University of Southampton in the UK, said she's been concerned that parents are reducing the nutritional diversity of their infants' diet without a great deal of evidence to support the practice.
To see how parents are feeding their infants, and whether that appears to have any influence on food allergies, Grimshaw and her colleagues collected food diaries from the parents of 1,140 babies.
The parents typically maintained the diet log for the first year of life, Grimshaw and her colleagues reported online July 25 in The Journal of Allergy and Clinical Immunology.
During that time, 41 children were diagnosed with a food allergy, and Grimshaw's group compared these infants to 82 similar babies without an allergy.
The researchers scored the babies' diets based on the combination of different foods they ate.
They found that babies without food allergies scored higher than babies with allergies on a diet that was rich in healthy, often homemade, foods - including fruits, vegetables, poultry and fish - and scant on processed foods such as pre-made meals, potato chips, cook-in sauces and bacon.
"The analysis showed that the infants who were having more fruits and vegetables and less commercially produced baby foods and also less adult foods were the ones who were less likely to develop an allergy by the time they were two," Grimshaw said.
"It's not that they didn't have commercially-made baby foods, it's just that they did not have them predominantly in their diet," she added.
The study could not determine why the fresher type of diet seemed to protect against food allergies. And the results do not prove that the dietary patterns caused the differences in allergy rates.
Wickman said that studies on diet and allergy are extremely difficult, and that it is a challenge for researchers to account for other factors that might influence what a child eats and his risk for developing a food allergy.
Still, it's possible that the foods themselves are responsible.
"We know that there are nutrients in the diet that educate the immune system. And one could argue that if they're not there in adequate amounts when the child's immune system is developing, that may be one way that this is working," Grimshaw told Reuters Health.
Wickman said that there is no evidence that avoiding allergenic foods, such as nuts, fish and eggs is beneficial in preventing food allergies.
Also, she said, there is very little risk in recommending that parents focus on fresh fruits and vegetables.
"Healthy food has so many good things, and maybe it also can reduce the risk of food allergy in the child," Wickman told Reuters Health.
Grimshaw said the results are just another reason for parents to feed their children fruits and vegetables and to try to serve home-made meals.
J Allergy Clin Immunol 2013.